Correction

Peginterferon Alfa-2b and Ribavirin for the Treatment of Chronic Hepatitis C in Blacks and Non-Hispanic Whites

N Engl J Med 2004; 351:1268September 16, 2004

Article

Peginterferon Alfa-2b and Ribavirin for the Treatment of Chronic Hepatitis C in Blacks and Non-Hispanic Whites (Original Article, N Engl J Med 2004:350;2265 - 2271) . On page 2266, in the right-hand column, lines 7 and 8 should have read “1000 mg of ribavirin (Rebetol, Schering-Plough) orally daily,” rather than “twice daily,” as printed. The Web version of the article has been corrected. We regret the error.